Alliqua Biomedical Inc is categorized under Biotechnology Products and Services in New York City, NY .
Alliqua Biomedical Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Richard Rosenblum, President at the company’s single location by writing to 850 3rd Avenue # 1801, New York City, New York NY 10022 or by phoning (646) 218-1450. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alliqua Biomedical Inc |
| Contact Person: | Richard Rosenblum, President |
| Address: | 850 3rd Avenue # 1801, New York City, New York 10022 |
| Phone Number: | (646) 218-1450 |
| Website Address: | alliqua.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Alliqua Biomedical Inc was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Richard Rosenblum, President for inquiries that concern Alliqua Biomedical Inc by calling the company number (646) 218-1450, as your correspondence is most welcome. Additionally, the physical location of the single location of Alliqua Biomedical Inc can be found at the coordinates 40.756939,-73.970032 as well as the street address 850 3rd Avenue # 1801 in New York City, New York 10022.
For its online presence, you may visit Alliqua Biomedical Inc’s website at alliqua.com and engage with its social media outlets through on Twitter and on Facebook.